Senores Pharmaceuticals Ltd

Net profit of Senores Pharmaceuticals rose 152.18% to Rs 32.38 crore in the quarter ended September 2025 as against Rs 12.84 crore during the previous quarter ended September 2024. Sales rose 56.08% to Rs 153.36 crore in the quarter ended September 2025 as against Rs 98.26 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales153.3698.26 56 OPM %32.2823.68 - PBDT48.7319.86 145 PBT40.6415.97 154 NP32.3812.84 152 Powered by Capital Market - Live

Senores Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 6 November 2025.Powered by Capital Market - Live

Securities in F&O Ban: RBL Bank, Angel One and HFCL shares are banned from F&O trading on 19 September 2025. Stocks to Watch: Senores Pharmaceuticals announced that it has further made an investment of $ 1,999,968 (120,480 equity shares at USD 16.60 each on a rights basis) in its arm, Senores Pharmaceuticals Inc., via a rights issue. Ramky Infrastructure announced that the Hyderabad Metropolitan Water Supply and Sewerage Board has executed a concessionaire agreement with the company's arm, Mallannasagar Water Supply. The total value of the project is Rs 2,085 crore. Sterling Holiday Resorts, a subsidiary of Thomas Cook, has launched the 'Sterling Hibis Vellore' resort. Sai Life Sciences announced that it has successfully opened a dedicated facility for veterinary API production in Bidar, India. With this expansion, the company aims to provide efficient and scalable manufacturing solutions to leading global animal health companies. Electronics Mart India announced that the company has commenced operations of a new multi-brand store under the brand name Bajaj Electronics in Andhra Pradesh. PNC Infratech announced that it has received a provisional completion certificate for the project 'Four Laning of LH 5308 from Mathura Bypass'. Texmaco Rail & Engineering announced that it has received an order worth Rs 87 crore from Ultratech Cement for BCFC wagons along with a brake van. John Cockerill India announced that it has received a contract from Tata Steel for the Push-Pull Pickling Line and Acid Regeneration Plant. Century Plyboards (India) announced that it has re-appointed Sajjan Bhajanka as Chairman and Managing Director for five more years, effective 1 April 2026. Metropolis Healthcare has acquired Ambika Pathology under a business transfer agreement. Post-transfer, the operations of Ambika Pathology are now being carried out under the company. Indian Hotels Company clarified that the report regarding the sale of New York's Pierre Hotel is misleading and speculative. The company does not own The Pierre in New York. Powered by Capital Market - Live

Senores Pharmaceuticals announced that the 8th Annual General Meeting(AGM) of the company will be held on 18 September 2025.Powered by Capital Market - Live

Senores Pharmaceuticals, Inc. (SPI), the wholly-owned US subsidiary of Senores, has entered into an agreement to acquire two Abbreviated New Drug Applications (ANDAs) from Teva Pharmaceuticals USA, Inc. According to IQVIA, the addressable market for these products in the U.S. stands at approximately $38 million (MAT December 2024), and nearly $120 million (MAT June 2025) as per specialty data aggregator Symphony. The company stated that the acquisition will be funded using proceeds from its recent Initial Public Offering (IPO), aligning with the objectives outlined in its Red Herring Prospectus. Senores Pharmaceuticals (Senores) is a global, research-driven pharmaceutical company engaged in developing and manufacturing a wide range of pharmaceutical products predominantly for the US, Canada, and other regulated and emerging markets across various therapeutic areas and dosage forms. The company's consolidated net profit surged 83.9% to Rs 19.73 crore in Q1 FY26 as against Rs 10.73 crore in Q1 FY25. Net sales jumped 63.9% YoY to Rs 130.30 crore during the quarter ended 30 June 2025. Powered by Capital Market - Live

Pondy Oxides & Chemicals Ltd, Mukand Ltd, Thyrocare Technologies Ltd and Southern Petrochemicals Industries Corporation Ltd are among the other gainers in the BSE's 'B' group today, 24 July 2025.Senores Pharmaceuticals Ltd soared 13.04% to Rs 689.25 at 24-Jul-2025 EOD IST. The stock was the biggest gainer in the BSE's 'B' group. On the BSE, 4.37 lakh shares were traded on the counter so far as against the average daily volumes of 21137 shares in the past one month. Pondy Oxides & Chemicals Ltd surged 13.02% to Rs 1071.5. The stock was the second biggest gainer in 'B' group. On the BSE, 1.6 lakh shares were traded on the counter so far as against the average daily volumes of 33186 shares in the past one month. Mukand Ltd spiked 12.13% to Rs 152.1. The stock was the third biggest gainer in 'B' group. On the BSE, 1.6 lakh shares were traded on the counter so far as against the average daily volumes of 45095 shares in the past one month. Thyrocare Technologies Ltd exploded 10.82% to Rs 1334.8. The stock was the fourth biggest gainer in 'B' group. On the BSE, 80817 shares were traded on the counter so far as against the average daily volumes of 5785 shares in the past one month. Southern Petrochemicals Industries Corporation Ltd spurt 10.35% to Rs 97.7. The stock was the fifth biggest gainer in 'B' group. On the BSE, 13.47 lakh shares were traded on the counter so far as against the average daily volumes of 48287 shares in the past one month. Powered by Capital Market - Live

Net profit of Senores Pharmaceuticals rose 83.88% to Rs 19.73 crore in the quarter ended June 2025 as against Rs 10.73 crore during the previous quarter ended June 2024. Sales rose 63.90% to Rs 130.30 crore in the quarter ended June 2025 as against Rs 79.50 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales130.3079.50 64 OPM %26.2226.82 - PBDT32.4816.98 91 PBT26.4913.46 97 NP19.7310.73 84 Powered by Capital Market - Live

Senores Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 23 July 2025.Powered by Capital Market - Live

Net profit of Senores Pharmaceuticals rose 11.86% to Rs 17.83 crore in the quarter ended March 2025 as against Rs 15.94 crore during the previous quarter ended March 2024. Sales rose 11.49% to Rs 114.21 crore in the quarter ended March 2025 as against Rs 102.44 crore during the previous quarter ended March 2024. For the full year,net profit rose 86.20% to Rs 58.56 crore in the year ended March 2025 as against Rs 31.45 crore during the previous year ended March 2024. Sales rose 85.65% to Rs 398.25 crore in the year ended March 2025 as against Rs 214.52 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales114.21102.44 11 398.25214.52 86 OPM %17.0221.86 -22.5219.39 - PBDT25.9121.32 22 87.4134.97 150 PBT20.6817.61 17 70.5724.95 183 NP17.8315.94 12 58.5631.45 86 Powered by Capital Market - Live

Senores Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 15 May 2025.Powered by Capital Market - Live